U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H13N5O4
Molecular Weight 267.2413
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADENOSINE

SMILES

NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O

InChI

InChIKey=OIRDTQYFTABQOQ-KQYNXXCUSA-N
InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H13N5O4
Molecular Weight 267.2413
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:17:31 UTC 2023
Edited
by admin
on Fri Dec 15 15:17:31 UTC 2023
Record UNII
K72T3FS567
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ADENOSINE
EP   HSDB   INCI   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INCI   USAN  
Official Name English
ADENOSINE [EP MONOGRAPH]
Common Name English
9-.BETA.-D-RIBOFURANOSYLADENINE
Common Name English
ADENOSINE [EP IMPURITY]
Common Name English
ADENOSINE [VANDF]
Common Name English
ADENOSINE [ORANGE BOOK]
Common Name English
ADENOSINE [MART.]
Common Name English
ADENOSCAN
Brand Name English
ADENOSINE [MI]
Common Name English
NSC-7652
Code English
SR 96225
Code English
ADENOSINE [JAN]
Common Name English
ADENOCARD
Brand Name English
ADENOSINE [USP MONOGRAPH]
Common Name English
ADENOSINE [USP-RS]
Common Name English
6-AMINO-9-.BETA.-D-RIBOFURANOSYL-9H-PURINE
Common Name English
ADENOSINE [HSDB]
Common Name English
ADENOSINE [INCI]
Common Name English
SR-96225
Code English
ADENOSINE [USAN]
Common Name English
Adenosine [WHO-DD]
Common Name English
Classification Tree Code System Code
DSLD 496 (Number of products:57)
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
LOINC 75136-2
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
WHO-ATC C01EB10
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
FDA ORPHAN DRUG 32388
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
NCI_THESAURUS C707
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
LOINC 75142-0
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
WHO-VATC QC01EB10
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
NDF-RT N0000178375
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
NDF-RT N0000175788
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
LOINC 75160-2
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID1022558
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
RXCUI
296
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY RxNorm
DRUG BANK
DB00640
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
CHEBI
16335
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
MESH
D000241
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
EVMPD
SUB00297MIG
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
WIKIPEDIA
ADENOSINE
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
DAILYMED
K72T3FS567
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
IUPHAR
2844
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
SMS_ID
100000078834
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
FDA UNII
K72T3FS567
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
MERCK INDEX
m1411
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY Merck Index
HSDB
7774
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
PUBCHEM
60961
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
ChEMBL
CHEMBL477
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
DRUG CENTRAL
90
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-389-9
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
RS_ITEM_NUM
1012123
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
NCI_THESAURUS
C207
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
NSC
7652
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
CAS
58-61-7
Created by admin on Fri Dec 15 15:17:31 UTC 2023 , Edited by admin on Fri Dec 15 15:17:31 UTC 2023
PRIMARY
Related Record Type Details
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
USP
TARGET -> AGONIST
Ki
INHIBITOR OF EXPRESSION->TARGET
Reduces the production of adenosine
Related Record Type Details
METABOLITE -> PARENT
Adenosine is broken down by adenosine deaminase, which is present in red cells and the vessel wall.
MAJOR
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.6; impurity G = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.6; impurity G = 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY